It is a pharma private limited company based in Delhi, Delhi, India, established in 2006.
2006 | Delhi, Delhi, India | ActiveShree Gobind Pharmaceuticals Private Limited, a active private limited company, was established on 14 February 2006 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24232DL2006PTC146275. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.40 M and a paid-up capital of ₹2.40 M.
It upholds a compliant status. Employing 12 professional, Its leadership includes Meenu Khaneja (Director), Sagar Khaneja (Director). Past directors included Hans Raj Miglani, Rakesh Kumar Khaneja, Sagar Khaneja. It holds ₹4.70 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 367 Anaj Mandifarash Bazar Shahdara Delhi-32, Delhi, Delhi, 110032.
U24232DL2006PTC146275
146275
14 February 2006
₹2.40 M
₹2.40 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Shree Gobind Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Meenu Khaneja | Director | 14 Feb 2006 | Current |
| Sagar Khaneja | Director | 11 Dec 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2011 | Past |
| Pramod Abcsdd | Director | 30 Apr 2019 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Shree Gobind Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 84.06% decrease. The company also saw a substantial fall in profitability, with a 79.61% decrease in profit. The company's net worth moved up by a moderate rise of 1.37%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Shree Gobind Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,700,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jan 2009 | Vijaya Bank | ₹4.70 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Shree Gobind Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Shree Gobind Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Gobind Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Shree Gobind Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Shree Gobind Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Progress on Sagar Khaneja was appointed as a Director was appointed as a Director on 11 Dec 2017 & has been associated with this company since 7 years 11 months . was documented.
Progress on A charge with Vijaya Bank of Rs. 4.70 M registered on 28 Jan 2009 with Charge ID 10143843 was modified on 30 Mar 2013. was documented.
A charge with Vijaya Bank amounted to Rs. 4.70 M with Charge ID 10143843 was registered on 28 Jan 2009. was recorded as a recent event.
Progress on Meenu Khaneja was appointed as a Director was appointed as a Director on 14 Feb 2006 & has been associated with this company since 19 years 9 months . was documented.
The CIN of Shree Gobind Pharmaceuticals Private Limited is U24232DL2006PTC146275.
Shree Gobind Pharmaceuticals Private Limited is headquartered at 367 Anaj Mandifarash Bazar Shahdara Delhi-32, Delhi, Delhi, 110032.
Shree Gobind Pharmaceuticals Private Limited was incorporated on 14 February 2006.
The current directors of Shree Gobind Pharmaceuticals Private Limited are
The primary industry of Shree Gobind Pharmaceuticals Private Limited is Manufacturing.
Shree Gobind Pharmaceuticals Private Limited is unlisted.
The authorized capital of Shree Gobind Pharmaceuticals Private Limited is ₹2.40 M, and the paid-up capital is ₹2.40 M.
The compliance status of Shree Gobind Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX